For instance, a 2023 study used targeted proteomics to detail the temporal evolution of AD pathology, identifying proteins such as SMOC1 and Spondin 1 (SPON1) that increase decades before symptom onset and associating these changes with specific pathological stages.5 The gene discussed is SPON1; the disease is Alzheimer disease.